Corrigendum:Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure:A randomized,open-label,parallel-group,non-inferiority phase III trail

导出

摘要 In the article titled,“Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure:A randomized,open-label,parallel-group,non-inferiority Phase III trail”published in pages 59-70,issue 1,vol.8 of Chronic Diseases and Translational Medicine.

出处《Chronic Diseases and Translational Medicine》 CAS CSCD 2024年第1期81-81,共1页 慢性疾病与转化医学（英文版）

关键词 INJECTION ANEMIA ALFA

分类号 R692.5 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献1

1Nan Chen,Changying Xing,Jianying Niu,Bicheng Liu,Junzhou Fu,Jiuyang Zhao,Zhaohui Ni,Mei Wang,Wenhu Liu,Jinghong Zhao,Ling Zhong,Xiongfei Wu,Wenge Li,Yuqing Chen,Wei Shi,Jianghua Chen,Aiping Yin,Ping Fu,Rong Wang,Gengru Jiang,Fanfan Hou,Guohua Ding,Jing Chen,Gang Xu,Yuichiro Kondo,Yuliang Su,Changlin Mei.Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure:A randomized,open-label,parallel-group,non-inferiority Phase III trail[J].Chronic Diseases and Translational Medicine,2022,8(1):59-70. 被引量：5

二级参考文献2

1张伟明,钱家麒.上海市透析登记及其结果分析[J].中国血液净化,2012,11(5):233-236. 被引量：83
2沈振敏,江朝强,张维森,徐琳,靳雅丽,朱彤,朱峰,林大庆.广州地区中老年男性血红蛋白和红细胞压积在饮酒与血压间的中介效应[J].中华心血管病杂志,2018,46(9):701-705. 被引量：5

共引文献4

1王曾,张阳,王琴,竺奇凡,陈洪宇.肾性贫血并发症的研究进展[J].中国血液净化,2022,21(7):469-472. 被引量：6
2中国非公立医院协会肾病透析专业委员会共识专家组,刘必成,梅长林,蒋红利,姚丽.长效红细胞生成刺激剂治疗肾性贫血中国专家共识(2024年版)[J].中华肾脏病杂志,2024,40(2):146-157.
3慢性肾脏病相关心肌病综合管理中国专家共识工作组,韦洮.慢性肾脏病相关心肌病综合管理中国专家共识(2024版)[J].中国血液净化,2024,23(8):561-580.
4甘金华.血常规红细胞参数对地中海贫血的诊断效能分析[J].中国医药指南,2024,22(25):95-98.

1Cai Xu,Deng-Gui Luo,Zhe-Yan Liu,Dong Yang,Dan-Dan Wang,Yuan-Zhao Xu,Jun Yang,Bo Fu,Ai-Rong Qi.Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents:A case report[J].World Journal of Clinical Cases,2022,10(35):13122-13128.
2Oncology and Translational Medicine Editorial Board[J].Oncology and Translational Medicine,2024,10(1).
3Nan Chen,Changying Xing,Jianying Niu,Bicheng Liu,Junzhou Fu,Jiuyang Zhao,Zhaohui Ni,Mei Wang,Wenhu Liu,Jinghong Zhao,Ling Zhong,Xiongfei Wu,Wenge Li,Yuqing Chen,Wei Shi,Jianghua Chen,Aiping Yin,Ping Fu,Rong Wang,Gengru Jiang,Fanfan Hou,Guohua Ding,Jing Chen,Gang Xu,Yuichiro Kondo,Yuliang Su,Changlin Mei.Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure:A randomized,open-label,parallel-group,non-inferiority Phase III trail[J].Chronic Diseases and Translational Medicine,2022,8(1):59-70. 被引量：5
4Author Guidelines[J].Chronic Diseases and Translational Medicine,2024,10(1):82-88.
5Bicheng Liu,Nan Chen,Jinghong Zhao,Aiping Yin,Xiongfei Wu,Changying Xing,Gengru Jiang,Junzhou Fu,Mei Wang,Rong Wang,Jianying Niu,Ping Fu,Zhaohui Ni,Fanfan Hou,Jiuyang Zhao,Jing Chen,Yuqing Chen,Wei Shi,Jianghua Chen,Wenge Li,Gang Xu,Ling Zhong,Wenhu Liu,Guohua Ding,Yuichiro Kondo,Changhe Yue,Changlin Mei.Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients:A randomized,open-label,parallel-group,noninferiority phase III trial[J].Chronic Diseases and Translational Medicine,2022,8(2):134-144. 被引量：3
6CHEN Xi,HAN Chao,ZHAO Jin Peng,SHEN Shi,WANG Li Yuan,REN Shou,WANG Tong Lei,MA Yan,XU Ze Chao,HUO Jun Sheng.Establishment of an Iron Deficiency Model by Iron Depletion in Pregnant Rats[J].Biomedical and Environmental Sciences,2024,37(2):210-215.
7Shanshan Cui,Guihua Xue,Xuelan Yan,Hua Zhang,Fang Wang,Yan Xu,Xuefei Li.Application Effect of Blended Education Strategy Based on the Learning Pass Platform in Phase III Cardiac Rehabilitation of Patients with Coronary Artery Disease[J].Journal of Contemporary Educational Research,2024,8(2):91-97.
8Yu He,Qi Liu,Yi-Wen Chen,Li-Jian Cui,Kai Cao,Zi-Hao Guo.Bowel preparation protocol for hospitalized patients ages 50 years or older:A randomized controlled trial[J].World Journal of Gastrointestinal Endoscopy,2024,16(1):18-28. 被引量：1
9廖伟,董秋瑾,李肖艳,王长中.论实践型教师教育者培训课程的构建[J].教师教育研究,2024,36(1):22-28. 被引量：2
10Si-Yang Liu,Song Dong,Xue-Ning Yang,Ri-Qiang Liao,Ben-Yuan Jiang,Qun Wang,Xiao-Song Ben,Gui-Bin Qiao,Jun-Tao Lin,Hong-Hong Yan,Li-Xu Yan,Qiang Nie,Hai-Yan Tu,Bin-Chao Wang,Jin-Ji Yang,Qing Zhou,Hong-Rui Li,Ke Liu,Wendy Wu,Si-Yang Maggie Liu,Wen-Zhao Zhong,Yi-Long Wu.Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC(CTONG1804):a multicenter open-label phase II study[J].Signal Transduction and Targeted Therapy,2024,9(1):249-258. 被引量：2

Chronic Diseases and Translational Medicine

2024年第1期

浏览历史

内容加载中请稍等...

Corrigendum:Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure:A randomized,open-label,parallel-group,non-inferiority phase III trail

参考文献1

二级参考文献2

共引文献4

相关作者

相关机构

相关主题

浏览历史